SINOVA-M-14040 B-type Natriuretic Peptide, (NT-proBNP) Quantitative Test Kit

linical Significance: Due to the very low levels of B-BNP in the serum/plasma of healthy individuals, an increase in B-BNP levels has excellent diagnostic value. B-BNP is primarily used to diagnose heart failure, monitor disease progression, evaluate treatment efficacy and prognosis, and assess the recovery of ventricular function in patients after AMI treatment.
Product Specifications: 20 tests/box
Product Shelf Life: 18 months when sealed in an aluminum foil pouch. Use within 1 hour after opening the pouch.
Product Storage: Store the test card at 2℃-30℃.
 
Usage Scenarios:
Hospitals and Clinics: For diagnosing heart failure, monitoring disease progression, and evaluating treatment efficacy and prognosis.
Cardiology Departments: For assessing ventricular function recovery in patients after Acute Myocardial Infarction (AMI) treatment.
Emergency Departments: For rapid diagnosis and management of patients presenting with symptoms of heart failure.
Diagnostic Laboratories: For routine testing of B-type Natriuretic Peptide (B-BNP) levels in patients with suspected or known heart conditions.
Suitable Countries and Regions:
Developed Countries: United States, Canada, Western Europe (e.g., Germany, France, UK), Japan, Australia, etc., where advanced diagnostic tools are used for comprehensive cardiac care and management.
Emerging Markets: China, India, Southeast Asia, Latin America, Eastern Europe, Middle East, etc., where healthcare systems are improving cardiac diagnostic capabilities and expanding access to modern diagnostic tools.
Global Health Programs: International health initiatives focused on enhancing cardiac care and improving diagnostic accuracy for heart failure in low-resource settings.